Fatemeh Gheybi Selected Research

Fatemeh Gheybi Research Topics

10	Neoplasms (Cancer) 12/2023 - 04/2016
4	Breast Neoplasms (Breast Cancer) 12/2023 - 04/2016
1	Liver Failure 10/2023
1	Melanoma (Melanoma, Malignant) 04/2023
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2023
1	COVID-19 01/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 07/2022
1	Hyperthermia 01/2017

5	Liposomes (Liposome)IBA 04/2023 - 01/2017
3	SilymarinIBA 12/2023 - 01/2023
2	AntioxidantsIBA 12/2023 - 12/2023
2	Silybin (Lagosa)IBA 10/2023 - 12/2021
2	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 01/2017
2	Amino Acids FDA Link 07/2022 - 04/2016
2	LigandsIBA 12/2021 - 04/2016
2	1-dodecylpyridoxal (PLD)IBA 05/2016 - 04/2016
2	liposomal doxorubicin (Doxil)FDA Link 05/2016 - 04/2016
1	IronIBA 12/2023
1	Saccharated Ferric Oxide (Venofer)FDA Link 12/2023
1	CadmiumIBA 12/2023
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2023
1	Glucose (Dextrose)FDA LinkGeneric 04/2023
1	GoldIBA 04/2023
1	IonsIBA 04/2023
1	AntigensIBA 01/2023
1	Drug CarriersIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	CurcuminIBA 04/2020
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 01/2017
1	1,2- distearoyl- sn- glycero- 3- phosphoethanolamine- N- methoxy- poly(ethylene glycol 2000)IBA 01/2017
1	human ERBB2 proteinIBA 05/2016
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 04/2016
1	Peptides (Polypeptides)IBA 04/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2016